GB0900484D0 - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
GB0900484D0
GB0900484D0 GBGB0900484.7A GB0900484A GB0900484D0 GB 0900484 D0 GB0900484 D0 GB 0900484D0 GB 0900484 A GB0900484 A GB 0900484A GB 0900484 D0 GB0900484 D0 GB 0900484D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agent
therapeutic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0900484.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority to GBGB0900484.7A priority Critical patent/GB0900484D0/en
Publication of GB0900484D0 publication Critical patent/GB0900484D0/en
Priority to PCT/GB2010/050034 priority patent/WO2010082044A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0900484.7A 2009-01-13 2009-01-13 Therapeutic agent Ceased GB0900484D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0900484.7A GB0900484D0 (en) 2009-01-13 2009-01-13 Therapeutic agent
PCT/GB2010/050034 WO2010082044A1 (en) 2009-01-13 2010-01-12 Unsaturated bicyclic heterocyclic derivatives as smo antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0900484.7A GB0900484D0 (en) 2009-01-13 2009-01-13 Therapeutic agent

Publications (1)

Publication Number Publication Date
GB0900484D0 true GB0900484D0 (en) 2009-02-11

Family

ID=40379487

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0900484.7A Ceased GB0900484D0 (en) 2009-01-13 2009-01-13 Therapeutic agent

Country Status (2)

Country Link
GB (1) GB0900484D0 (en)
WO (1) WO2010082044A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012004134A2 (en) 2009-08-26 2017-06-20 Takeda Pharmaceuticals Co "fused heterocyclic ring-derived compound, prodrug, medicament, and use of the compound or salt or a prodrug thereof"
CN103214456B (en) * 2013-04-20 2015-02-25 郎恒元 Benzimidazole compound with antitumour activity as well as preparation method and application thereof
NZ724691A (en) 2014-03-24 2018-02-23 Guangdong Zhongsheng Pharmaceutical Co Ltd Quinoline derivatives as smo inhibitors
US10301292B2 (en) 2014-11-26 2019-05-28 Takeda Pharmaceutical Company Limited Bicyclic compound
CA3056890A1 (en) * 2017-03-17 2018-09-20 Regents Of The University Of Colorado, A Body Corporate Indazole inhibitors of fructokinase (khk) and methods of use in treating khk-mediated disorders or diseases
WO2021197333A1 (en) * 2020-03-31 2021-10-07 浙江养生堂天然药物研究所有限公司 Pharmaceutical combination and use thereof
WO2025215121A1 (en) * 2024-04-09 2025-10-16 Imperial College Innovations Limited Hedgehog acyltransferase inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
US2789118A (en) 1956-03-30 1957-04-16 American Cyanamid Co 16-alpha oxy-belta1, 4-pregnadienes
US2990401A (en) 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
US3048581A (en) 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3749712A (en) 1970-09-25 1973-07-31 Sigma Tau Ind Farmaceuti Triamcinolone acetonide esters and process for their preparation
SE378109B (en) 1972-05-19 1975-08-18 Bofors Ab
SE378110B (en) 1972-05-19 1975-08-18 Bofors Ab
US3996359A (en) 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
CA2452152A1 (en) 2001-07-02 2002-10-10 Sinan Tas Use of cyclopamine in the treatment of psoriasis
US20080118493A1 (en) 2003-07-15 2008-05-22 Beachy Philip A Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity
ES2462341T3 (en) 2004-12-10 2014-05-22 Msd Italia S.R.L. Heterocyclic derivatives such as histone deacetylase inhibitors (HDAC)

Also Published As

Publication number Publication date
WO2010082044A1 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
GB0908957D0 (en) Therapeutic agents
SG10201506840QA (en) Cytotoxicity-inducing therapeutic agent
IL220526A0 (en) Kokumi-imparting agent
IL220527A0 (en) Kokumi-imparting agent
GB0920846D0 (en) Defenin inducing agent
GB0900484D0 (en) Therapeutic agent
GB0915319D0 (en) Combination medicament
GB0916997D0 (en) Combination therapy
GB0907973D0 (en) Combination therapy
GB0910493D0 (en) Therapeutic agents
GB0906026D0 (en) Therapeutic compounds
GB0919821D0 (en) Therapeutic agents
GB0914533D0 (en) Therapeutic agents
GB0919824D0 (en) Therapeutic agents
GB0919829D0 (en) Therapeutic agents
GB0902450D0 (en) Therapeutic agents
GB0903949D0 (en) Therapeutic agents
GB0907971D0 (en) Therapeutic agents
GB0919820D0 (en) Therapeutic agents
GB0919819D0 (en) Therapeutic agents
GB0915586D0 (en) Therapeutic agents
GB0919825D0 (en) Therapeutic agents
GB0911965D0 (en) Therapeutic agents
GB0922098D0 (en) Therapeutic use
GB201003727D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)